Answering the Call in Severe Asthma: Expanding Roles for Biologic Treatment Regimens

May 22 @ 6:30 pm 8:30 pm EDT

Supported By: AstraZeneca

This live Call-a-Colleague™ educational program will guide attendees through the long-term management of severe asthma. Expert faculty will provide actionable recommendations on evaluation strategies that consider underlying mechanism of disease, data on newer biologic treatment options, and most importantly, the use of these therapies in current day practice. Interspersed throughout the program are brief Call-a-Colleague™ video calls in which faculty consult with their specialist colleagues to inform management decisions and gain additional insights into health disparities in asthma care and access, comorbid disease, initiation of biologics early within the disease course, and finally, treatment selection for challenging clinical cases.


Njira Lucia Lugogo, MD, MS
Associate Professor of Internal Medicine
Asthma Program Director Division of Pulmonary & Critical Care Medicine
University of Michigan Pulmonary & Critical Care Medicine
Ann Arbor, Michigan

Jonathan Corren, MD
Clinical Faculty David Geffen School of Medicine
University of California, Los Angeles

Medical Director
Jonathan Corren M.D. and Associates
Los Angeles, California

Reynold A. Panettieri, Jr., MD
Professor of Medicine
Robert Wood Johnson Medical School

Vice Chancellor
Clinical & Translational Science Director
Rutgers Institute for Translational Medicine & Science Emeritus

Professor of Medicine
University of Pennsylvania Child Health Institute of New Jersey Rutgers
The State University of New Jersey
New Brunswick, New Jersey

Monica Kraft, MD
System Chair
Samuel Bronfman Department of Medicine; Murray M. Rosenberg

Professor of Medicine
Icahn School of Medicine at Mount Sinai Mount Sinai Health System
New York, New York